Objectives: MicroRNAs (miRNAs) are considered as the cellular regulators which posttranscriptionally modulate gene expression in diverse biological processes including cell development and immunity. In this study, we investigated functions of miR-181d in dendritic cells (DCs) maturation, and the underlying mechanisms were also explored. Results: Overexpression of miR-181d per se is sufficient to promote DCs maturation, and up-regulate CD80 and CD83 expressions without LPS. Besides, we showed that miR-181d activated NF-κB pathway and also promoted the expression of proinflammatory cytokine IL12 and TNF-α. Inhibition of NF-κB pathway suppressed DCs maturation. Luciferase reporter assay and target gene knockdown assay indicated that miR-181d targets regulator cylindromatosis (CYLD), a primary negative regulator of NF-κB pathway. MLR assay showed that miR-181d-transfected DCs could promote T-cell proliferation than iDCs in vitro.
CD80 and CD83. 10 Haematopoietic progenitor cells or peripheral blood monocytes are used to produce mDCs in vitro by co-culturing with growth factors and cytokines or microbial stimuli to induce maturation and enhance immunological functions. 11 The duration of stimulation could regulate DCs maturation status and immunophenotype; 24-hour stimulation shows a clear alternation of immunophenotype and elevated expression of CD markers compared with the 6-hour treatment.
12
MicroRNAs (miRNAs) are small, non-coding and conserved RNA molecules around 19-24 nucleotides, that post-transcriptionally modulate gene expression and cellular processes, thereby influence cell fate and function. 13 Numerous miRNAs have been identified and characterized on the varying genes expression patterns and functions, and the roles of miRNAs are being studied in almost every area of biology. A panel of miRNAs has been reported to regulate DCs development, maturation and function. miR-155, one of the well-characterized miRNAs in DCs maturation, is part of a negative feedback loop, which suppresses inflammatory cytokine production in response to stimulus. miR-155 targets TAB 2 and SOCS1, which are the important transduction molecules in cytokine signalling. In addition, miR-155 also drives IL-12p70 production in mDCs, thus potentially promoting the potency of monocytederived DCs in Th1 immune responses. 14,15 miR-146a overexpression is
shown to inhibit the expression of several DC-specific surface markers such as CD80, CD86, HLA-DR and CCR7 molecules. 16 Overexpression of miR-301a inhibited IL-12, IL-6 and TNFα production in DCs and modulated T-cell responses; however, there is no effect on MHC class II, CD80, CD86 or CD40 expression. 17 Likewise,up-regulation of the miRNA let-7i in DCs is required for DCs maturation following lipopolysaccharide (LPS) treatment. Inhibition of let-7i down-regulated the expression of the co-stimulatory molecules CD80 and CD86, as well as pro-inflammatory cytokine IL6 and TNF-α production. T-cell responses to antigen presented by DCs were also compromised. 18 In this study, we screened for the candidate miRNAs which control DCs maturation. LPS treatment promoted expression of numerous miRNAs in DCs, highlighting their potential regulatory role for DCs maturation. We demonstrated that the altered miR-181d level modulates DCs morphology, promotes cytokine release and elevates DCs maturation markers expression. Bioinformatics analysis and luciferase reporter assay indicated cylindromatosis (CYLD) is a target gene of miR-181d. Our study revealed that miR-181d regulated DCs maturation and functional status by activating NF-κB pathway and suppressing CYLD transcription and translation.
| MATERIALS AND METHODS

| Generation of DCs from human peripheral blood
Human peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Paque (1.077 g/mL; GE Healthcare) density gradient centrifugation from the buffy coat fraction of anticoagulated blood. Monocytes were purified from PBMCs from the middle layer after the centrifugation.
About 1 × 10 6 cells/mL were cultured in 2 mL AIM V containing 10% autologous plasma, 50 ng/mL recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF; Peprotech), 50 ng/mL recombinant interleukin 4 (IL-4; Peprotech) and 1% penicillin/streptomycin (P/S; Life technologies) in six-well flat-bottomed plates. The adherent cells were selected by overnight culture. Medium was half-changed every 2 days, the maturation of monocytes derived was induced by 100 ng/mL LPS on day 6, and mDCs were collected on day 7. PBMC were collected from 14 healthy donors (30-60 years old), and all donors gave their written consent for supplying blood for scientific research. All experiments conducted using human materials were approved by the ethics committee of The Chinese University of Hong Kong. 
| Characterization of DC by flow cytometry
| Cytokine analysis
Dendritic cell supernatants were collected on day 0, 2, 4 and 6, and frozen at −20 • C until ELISA analysis. Quantification measurements of cytokines and chemokines were performed using IL12 SEH00544A, Single-Analyte ELIS Array Kits (QIAGEN, Hilden, Germany) according to the manufacturer's instructions.
| Quantitative real-time PCR
Total RNA, including miRNA, was extracted from cells using the miR-CURY RNA isolation kit (Exiqon, Denmark) following the manufacturer's instruction. RNA concentrations were measured with NanoDrop instrument (Thermo Scientific, Waltham, MA, USA). miRNA expression was assessed by qRT-PCR analysis using miScript SYBR Green PCR Kit (Qiagen). miRNA-specific primers were designed by miRprimer software and the cDNA synthesis was followed as previously reported. 19 All the oligo primers were synthesized by Tech Dragon Ltd. For mRNA expression, 1 μg of total RNA was reverse transcribed using High-Capacity
Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA) as specified by the manufacturer, qRT-PCR amplification was done using SYBR Select
Master Mix (Applied Biosystems, Foster City, CA, USA). All qRT-PCR analyses were performed using abi prism Vii 7 Sequence Detection System (PerkinElmer Biosystems, Waltham, MA , USA). Relative miRNA and mRNA levels were calculated using the 2 △△Ct method; GAPDH and U6 were used for mRNA and miRNA normalization respectively, and primer sequences are detailed in Tables S2 and S3 . 
| Mixed lymphocyte reaction
PBMCs were isolated from healthy donors using Ficoll gradient centrifugation, and were suspended in AIM V with 10% autologous serum for 2 hours; the non-adherent cells were collected and cultured in Obispo, CA, USA) was performed to detect T-cell proliferation, and absorbance at OD of 490 nm was measured by a microplate reader.
| Identification of miRNAs target
Genome-wide mRNA expression analysis was performed to compare the gene expression profile between miRNA mimics-transfected DCs and scrambled mimics-transfected cells. mRNA transcripts with more than 2-fold down-regulated were selected and compared with the in silico targets from four publicly available databases (miRanda, PITA, miR-Walk and TargetScan 6.2), generating a list of candidate target mRNAs. Meanwhile, the target genes and signalling-related genes were analysed by Ingenuity ® Pathway Analysis (IPA). 
| Ingenuity pathway analysis (IPA)
Data
| Signal transduction in DCs maturation
To identify the key signalling pathways involved in DCs maturation, two or three key genes were selected and validated by the qRT-PCR. On day 6, iDCs were transfected with the miRNA mimics at 50 nmol/L. In some experiments, iDCs were pre-treated with PD98059 (25 μmol/L, Tocris, Bristol, UK) and Bay 11-7821 (20 μmol/L, Tocris), the pharmacological inhibitors of ERK pathway and NF-κB pathway respectively. Control group received an equivalent amount of vehicle (DMSO). Cell maturation was characterized by the CD80 and CD83 expressions using qRT-PCR.
| Luciferase reporter assays
The sequences of the target genes at 3′ UTR were retrieved from 
| Western blot assay
Total protein was extracted using N-PER Neuronal Protein Extraction Reagents (#87792; Thermo Scientific), and protein concentration was measured by Bradford assay (Bio-Rad, CA, USA). 
| Statistical analysis
Data presented in the graphics are from at least three independent experiments. Statistical difference between groups was analysed by two-tailed Student's t tests. Value of P<.05 was considered significant (Excel; GraphPad Prism 6).
| RESULTS
| LPS promotes DCs maturation
Monocytes isolated from peripheral blood of healthy human donors were differentiated into iDCs with GM-CSF, IL4 growth factors and Counter; the mDCs were bigger than iDC ( Figure 1B) . The expression of DC surface markers including CD80, CD83 and CD86 were elevated after DCs maturation ( Figure 1C) . Meanwhile, the expressions of these cell surface markers were assessed by qRT-PCR over a 7-day culture; CD80 and CD83 were strongly induced after exposure to LPS ( Figure 1D ). Nearly 2-fold induction of IL-12p70 cytokine secretion was detected in the culture supernatant after 24 hours post-LPS treatment (Fig. S1a) . Consistently, the expression of CD83, CD80 and CD86 were significantly higher in LPS-treated group compared with the iDCs by flow cytometry; however, CD14 expression remained unchanged (Fig. S1b) 
| Identification of differentially expressed miRNAs between iDCs and mDCs
We attempted to identify miRNAs required for DC differentiation and maturation by combining the multiple microarray data sets. The raw CEL files of mDCs (accession number GSE23371) and (accession number GSE21708) data sets were downloaded from the National Center for Biotechnology Information Gene Expression Omnibus (GEO) database. 15, 20 The blast analysis revealed that a total of 36 miRNAs were differentially expressed ( Figure 2A ). Then we measured the expres- 
| miR-181d regulates DCs maturation and modulates cell surface markers expression and cytokine release
Dendritic cell maturation status is important for antigen presentation and we measured the expression of maturation markers (CD80 and CD83) in the miRNA-transfected iDCs by qRT-PCR ( Figure 3A) .
To identify the miRNAs required for CD marker expression, we drew the hierarchically clustered heatmap according to the expression profiles of CD80 and CD83 using Qlucore software. As shown in (Table S1 ). To identify the potential miR-181d targets, the gene list was imported into IPA software, and the top associated signalling pathways involved in the network were identified including NF-κB, MAPK and Akt pathways (red colour-filled circle) ( Figure 3D ). This network was associated with haematological disease and immunological disease (figure was not shown).
| NF-kB signalling pathway is modulated by miR-181d in mDCs
miR-181d is shown to be a key regulator of cellular differentiation in human mammary epithelial MCF-10A cells and associated with the inflammation response. 21 However, the functional specificity of miR- by miR-181d respectively ( Figure 4C ). We also qPCR-measured the F I G U R E 5 Cylindromatosis (CYLD) was targeted by miR-181d (A) iDCs at day 6 were transfected with miRNA mimics and scrambled control (50 nmol/L), followed by LPS (100 ng/mL) for 24 hours. The targets of miR-181d were predicted by the bioinformatics tool and were screened by qRT-PCR. GAPDH was served as the internal control. qRT-PCR measurements were performed in triplicate (n=3) the pathway inhibitors in miR-181d-overexpressing DCs. As shown in Figure 4D , blockade of NF-κB pathway inhibited the up-regulation of both maturation markers induced by miR-181d; inhibition of MAPK pathway selectively suppressed CD80 expression. To further test the role of miR-181d on DCs maturation, we evaluated the effect of the expression levels of CD80 and CD83 as well as the abundance of phosphorylated p65 after depletion of miR-181d. We confirmed that transfection of anti-miR-181d pronouncedly inhibited its endogenous expression ( Figure 4E) . Expression of the cell surface markers CD80
and CD83 revealed mild but insignificant reduction in anti-miR-181d-transfected DCs ( Figure 4F ). Western blotting showed that inhibition of miR-181d could not promote phosphorylation of p65 compared to N.C.-transfected DCs ( Figure 4G ). Taken together, these results
showed that miR-181d could activate NF-κB pathway, and DCs maturation marker up-regulation is mainly dependent on NF-κB pathway, rather than MAPK pathway.
| CYLD was targeted by miR-181d
Given that miR-181d induced the NF-κB pathway, we attempted to identify its downstream targets for DCs maturation. In the murine forebrain, HtrA1 were identified as the target of miR-181d.
22
CDX2, a known positive regulator of hepatocyte differentiation, was regulated by miR-181d and targeted SOAT2 in hepatic cells.
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Then we qPCR-measured the expression levels of the putative miR-181d direct targets generated by IPA. As shown in Figure 5A , Figure 5B). We tested whether miR-181d could directly repress the identified mRNA targets by interacting with their 3′UTR
regions. The 3′UTRs of ESR1, DUSP10 and CYLD were cloned into pmirGLO reporter vector, downstream of firefly luciferase element.
The luciferase reporters and miR-181d mimics were co-transfected into 293T cells, and the luciferase activity was measured by the bioluminescence analyser in 48 hours post-transfection. As shown in Figure 5C , overexpression of miR-181d significantly reduced CYLD and ESR1 luciferase reporter activity by 30% and 20% respectively, and also influence DUSP10 luciferase reporter assay slightly. Next,
we examined the role of ESR1, DUSP10 and CYLD in CD80 and CD83 expressions. We first confirmed that silencing of CYLD, ESR1
or DUSP10 by siRNA effectively down-regulated their endogenous expression level in DCs by qRT-PCR ( Figure 5D ). CD80 and CD83
expressions in DCs transfected with siESR1, siDUSP10 and siCYLD were then determined by qRT-PCR. The results showed that silencing of CYLD significantly up-regulated the expression levels of CD80 and CD83; however, there was no effect upon silencing of ESR1 and DUSP10 ( Figure 5E ). Immunoblot consistently demonstrated that CYLD protein expression was strongly inhibited upon miR-181d overexpression. A growing number of dendrites were observed in the miR-181d-transfected group ( Figure 5F ). Moreover, we found that silencing of CYLD by siRNA transfection (siCYLD) elevated the expression of p-p65 measured using Western blotting ( Figure 5G ).
Taken together, we demonstrate that miR-181d could regulate human DCs maturation and cytokine production, and it can activate NF-κB pathway potentially by targeting CYLD ( Figure 5H ).
| DISCUSSION
Dendritic cells maturation upon stimulation is essential for the initiation of allergic reactions, and then become highly efficient APC for naïve T lymphocytes. 24 In this study, we provide a mechanistic insight underlying the miR-181d-mediated DC differentiation and maturation for immunity. First, a specific miR-181d variant was up-regulated during human monocyte differentiation from iDCs and mDCs. We also demonstrated that overexpression of miR-181d enhanced DCs maturation markers including CD80 and CD83 transcription during human DC differentiation. Second, miR-181d is a critical regulator of DCs maturation via NF-κB signalling pathway and cytokine production. Third, mechanistically, miR-181d activates NF-κB pathway and suppresses CYLD (a negative regulator of NF-κB) transcription and translation during DCs maturation.
Dendritic cells maturation could be characterized by cell surface markers. It was previously reported that CD83 was the most specific marker in mature DCs. 25 For the cell surface markers, CD80 is expressed on activated B and T cells, macrophages and dendritic cells. is expressed on monocytes/macrophages, dendritic cells, activated B and T cells, and astrocytes; however, CD86 showed an earlier expression in immune response than CD80. CD80 could also bind to CD28
to signal T-cell activation
27
. For HLA-DR, it is expressed in B cells, activated T cells, monocytes/macrophages and dendritic cells, which plays a critical role to present peptide presentation to CD4+ T cells. Previous study showed that multiple cell surface markers including HLA-DR, CD80, CD86, CD83, CD40 and CD11c showed increased expression upon the maturation of DCs. 28 According to the previous reports and our results, we mainly focus on CD80 and CD83 to characterize DCs maturation in our study.
Recent characterization and understanding of miRNA-mRNA regulatory networks substantially facilitate the development of immune therapy for human diseases. 29 In addition, whole transcriptome expression analysis and miRNA profiling also provide mechanistic insight into DC developmental biology and help identify biomarkers for DC potency. 14 miR-181d was first identified in B-lymphoid cells in mouse bone marrow, and its ectopic expression could increase the fraction of B-lineage cells in vitro and in vivo. 30 Previous study showed that miR-181a and miR-181b induced the apoptosis of glioma cells and function as potential tumour suppressors. 31 Subsequently, miR-181d was reported to act as a tumour suppressor in glioma by targeting K-ras and Bcl-2. 32 However, miR-181b/d was shown to be up-regulated in early stage of hepatocarcinogenesis induced by CDAA diet, and miR-181b is required to promote hepatocarcinogenesis. 33 Our study indicates a direct role of NF-κB pathway in regulating miR-181d-mediated DCs maturation. NF-κB is an important transcription factor of the nuclear factor κ B (NF-κB)/Rel family, which play a pivotal role in inflammatory and immune responses. 34 There are five family members in mammals: RelA (p65), c-Rel, RelB, NF-κB1 (p105/p50) and NF-κB2 (p100/p52). 35 The p65/p50 heterodimer is the major form of NF-κB in most cells, and it regulates a number of genes which play a pivotal role in the immune response, inflammation and development. 36 NF-κB signalling pathway could affect DCs maturation marker expression and functional characteristics dependent on different stimuli. 37 NF-κB was reported to regulate DCs maturation, immune response and protection of DCs from apoptosis.
38,39
Mutant Escherichia coli (EPEC) was shown to activate NF-kB signalling pathway, secrete large amounts of pro-inflammatory cytokines and promote CD80 and CD83 expression when incubated with myeloid DCs. 40 However, no reports address the role of NF-κB signalling pathway in DCs maturation induced by miR-181d, which could target CYLD in DCs. A recent report has shown that miR-21 could involve in a positive feedback loop to activate NF-κB signalling pathway, by targeting PTEN expression.
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CYLD is a deubiquitination enzyme, which contains a deubiquitinase domain and three glycine-rich domains. The deubiquitinase domain can regulate signal transduction pathways by deubiquitinating signal molecules. 41 CYLD has been widely considered as a negative regulator for both canonical and non-canonical NF-κB pathways.
42
CYLD could inhibit tumour cell proliferation by blocking Bcl-3-dependent NF-κB pathway. 43 CYLD was also reported to be associated with multiple types of human cancers, including melanoma, colon, hepatocellular carcinomas and kidney. [44] [45] [46] Recently, CYLD was demonstrated to regulate the function of murine regulatory T cells. 47 However, the role of CYLD in DCs maturation and activation remains elusive.
Our study revealed that miR-181d regulates DCs maturation and functional state by targeting CYLD. Overexpressing miR-181d can promote DCs undergo maturation, exhibit higher surface expression of co-stimulatory molecules CD80 and CD83, and activate NF-κB pathway followed by the shift of cytokine profile from pro-inflammatory mediators. In this study, we propose that miR-181d could serve as an adjuvant to induce DCs maturation and enhance immunity.
